Headache & Migraine
PHILADELPHIA – As the number of migraine headache days per month rises, the prevalence of comorbidities like insomnia and depression also increase...
From the Journals
Health care clinicians caring for persons who experience migraine should consider screening for food insecurity as a potential contributor to...
SAN ANTONIO – The intervention also led to reductions in anxiety, depression, and stress symptoms and an increase in gray matter volume.
News from the FDA/CDC
The treatment binds to calcitonin gene-related peptide and is the first therapy to reduce the frequency of episodic cluster headache attacks.
MILWAUKEE – Pain scores and opioid use may plummet with the noninvasive therapy.
PHILADELPHIA – An orally dissolving tablet formulation has significant effects on pain relief and functional ability at 60 minutes post dose.
PHILADELPHIA – Dr. Alan Rapoport asks Dr. Stewart Tepper to summarize some of
PHILADELPHIA – The treatment appears to have the same safety and tolerability in this population as among patients...
PHILADELPHIA – Patients studied had failed to get relief from other treatments.
Patients with migraine may be willing to trade off efficacy for better adverse event profiles.